Clinical Trials Logo

Multiple Myeloma Stage III clinical trials

View clinical trials related to Multiple Myeloma Stage III.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03428373 Active, not recruiting - Clinical trials for Multiple Myeloma in Relapse

Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma

RithMM
Start date: January 17, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

The intended study is designed as a a phase IV pragmatic multicenter randomized controlled clinical trial, comparing the impact of two different therapies including ASA vs. Rivaroxaban in newly diagnosed or relapsed and refractory multiple myeloma patients treated with Lenalidomide Dexamethasone (Len-Dex) combination therapy. The pilot feasibility study was conducted in preparation for this randomized controlled trial designed to assess the effect of an intervention.